O-GlcNAcylation and inflammation: A vast territory to explore

Frontiers in Endocrinology

Volumn 5, Issue DEC, 2014, Pages

  Baudoin, Léa ^a,b   Issad, Tarik ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

Cytokines; Diabetes; Inflammation; Macrophages; Metabolic syndrome; NF B; Nitric oxide; O GlcNAc glycosylation

Indexed keywords

COLONY STIMULATING FACTOR; GAMMA INTERFERON; GLUCOSAMINE PHOSPHATE ACETYLTRANSFERASE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; N ACETYLGLUCOSAMINE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN P100; PROTEIN P105; SYNAPTOTAGMIN I; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELB; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; INFLAMMATION; NEUROPROTECTION; NONHUMAN; O GLCNACYLATION; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 84920154656     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00235     Document Type: Article

References (83)

1. Hotamisligil GS. Inflammation and metabolic disorders. Nature (2006) 444(7121):860-7. PubMed PMID: 17167474.
2. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation (2006) 116(11):3015-25. PubMed PMID: 17053832.
3. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation (2002) 106(16):2067-72. PubMed PMID: 12379575.
4. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab (2000) 85(8):2970-3. PubMed PMID: 10946914.
5. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middleaged women. The American journal of clinical nutrition (2002) 75(3):492-8. PubMed PMID: 11864854.
6. Dickinson S, Hancock DP, Petocz P, Ceriello A, Brand-Miller J. High-glycemic index carbohydrate increases nuclear factor-kappaB activation in mononuclear cells of young, lean healthy subjects. The American journal of clinical nutrition (2008) 87(5):1188-93. PubMed PMID: 18469238.
7. de Carvalho Vidigal F, Guedes Cocate P, Goncalves Pereira L, de Cassia Goncalves Alfenas R. The role of hyperglycemia in the induction of oxidative stress and inflammatory process. Nutr Hosp (2012) 27(5):1391-8. PubMed PMID: 23478683.
8. Dandona P, Mohanty P, Ghanim H, Aljada A, Browne R, Hamouda W, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab (2001) 86(1):355-62. PubMed PMID: 11232024.
9. Issad T, Masson E, Pagesy P. O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab (2010) 36(6 Pt 1):423-35. PubMed PMID: 21074472.
10. Gao Y, Miyazaki J, Hart GW. The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch Biochem Biophys (2003) 415(2):155-63. PubMed PMID: 12831837.
11. Goldberg HJ, Whiteside CI, Hart GW, Fantus IG. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells. Endocrinology (2006) 147(1):222-31. PubMed PMID: 16365142.
12. Andrali SS, Qian Q, Ozcan S. Glucose mediates the translocation of NeuroD1 by O-linked glycosylation. The Journal of biological chemistry (2007) 282(21):15589-96. PubMed PMID: 17403669.
13. Kuo M, Zilberfarb V, Gangneux N, ChristeffN, Issad T. O-glycosylation of FoxO1 increases its transcriptional activity towards the glucose 6-phosphatase gene. FEBS Lett (2008) 582(5):829-34. PubMed PMID: 18280254.
14. Kuo M, Zilberfarb V, Gangneux N, ChristeffN, Issad T. O-GlcNAc modification of FoxO1 increases its transcriptional activity: A role in the glucotoxicity phenomenon? Biochimie (2008) 90:679-85. PubMed PMID: 18359296.
15. Guinez C, Filhoulaud G, Rayah-Benhamed F, Marmier S, Dubuquoy C, Dentin R, et al. OGlcNAcylation increases ChREBP protein content and transcriptional activity in the liver. Diabetes (2011) 60(5):1399-413. PubMed PMID: 21471514.
16. Fardini Y, Masson E, Boudah O, Ben Jouira R, Cosson C, Pierre-Eugene C, et al. OGlcNAcylation of FoxO1 in pancreatic beta cells promotes Akt inhibition through an IGFBP1-mediated autocrine mechanism. Faseb J (2014) 28(2):1010-21. PubMed PMID: 24174424.
17. Issad T, Kuo M. O-GlcNAc modification of transcription factors, glucose sensing and glucotoxicity. Trends Endocrinol Metab (2008) 19(10):380-9. PubMed PMID: 18929495.
18. Park SY, Ryu J, Lee W. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes. Exp Mol Med (2005) 37(3):220-9. PubMed PMID: 16000877.
19. Lima VV, Giachini FR, Carneiro FS, Carneiro ZN, Fortes ZB, Carvalho MH, et al. Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli-VASOACTIVE PEPTIDE SYMPOSIUM. J Am Soc Hypertens (2008) 2(6):410-7. PubMed PMID: 19884969.
20. Luo B, Soesanto Y, McClain DA. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arterioscler Thromb Vasc Biol (2008) 28(4):651-7. PubMed PMID: 18174452.
21. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV, et al. Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance. Nature (2008) 451(7181):964-9. PubMed PMID: 18288188.
22. Lefebvre T, Dehennaut V, Guinez C, Olivier S, Drougat L, Mir AM, et al. Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease. Biochim Biophys Acta (2009) 1800(2):67-79. PubMed PMID: 19732809.
23. Weigert C, Klopfer K, Kausch C, Brodbeck K, Stumvoll M, Haring HU, et al. Palmitateinduced activation of the hexosamine pathway in human myotubes: increased expression of glutamine:fructose-6-phosphate aminotransferase. Diabetes (2003) 52(3):650-6. PubMed PMID: 12606504.
24. Busch AK, Cordery D, Denyer GS, Biden TJ. Expression profiling of palmitate- and oleateregulated genes provides novel insights into the effects of chronic lipid exposure on pancreatic betacell function. Diabetes (2002) 51(4):977-87. PubMed PMID: 11916915.
25. Schrijvers BF, De Vriese AS. Novel insights in the treatment of diabetic nephropathy. Acta Clin Belg (2007) 62(5):278-90. PubMed PMID: 18229460.
26. Haneda M, Koya D, Isono M, Kikkawa R. Overview of glucose signaling in mesangial cells in diabetic nephropathy. J Am Soc Nephrol (2003) 14(5):1374-82. PubMed PMID: 12707407.
27. Stockand JD, Sansom SC. Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol Rev (1998) 78(3):723-44. PubMed PMID: 9674692.
28. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. The Journal of clinical investigation (1998) 101(1):160-9. PubMed PMID: 9421478.
29. Weigert C, Friess U, Brodbeck K, Haring HU, Schleicher ED. Glutamine:fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells. Diabetologia (2003) 46(6):852-5. PubMed PMID: 12802498.
30. Goldberg HJ, Whiteside CI, Fantus IG. The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C-beta I and -delta. The Journal of biological chemistry (2002) 277(37):33833-41. PubMed PMID: 12105191.
31. James LR, Tang D, Ingram A, Ly H, Thai K, Cai L, et al. Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation. Diabetes (2002) 51(4):1146-56. PubMed PMID: 11916938.
32. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes (1999) 48(4):855-64. PubMed PMID: 10102704.
33. Hofmann MA, Schiekofer S, Kanitz M, Klevesath MS, Joswig M, Lee V, et al. Insufficient glycemic control increases nuclear factor-kappa B binding activity in peripheral blood mononuclear cells isolated from patients with type 1 diabetes. Diabetes care (1998) 21(8):1310-6. PubMed PMID: 9702439.
34. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 42(2):222-32. PubMed PMID: 10064103.
35. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 414(6865):813-20. PubMed PMID: 11742414.
36. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, et al. Hyperglycemiainduced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A (2000) 97(22):12222-6. PubMed PMID: 11050244.
37. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes (2005) 54(6):1615-25. PubMed PMID: 15919781.
38. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nfkappa B by a posttranslational mechanism. Cell (1986) 47(6):921-8. PubMed PMID: 3096580.
39. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 46(5):705-16. PubMed PMID: 3091258.
40. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol (2009) 1(4):a000034. PubMed PMID: 20066092.
41. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesityand diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (New York, NY (2001) 293(5535):1673-7. PubMed PMID: 11533494.
42. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nature medicine (2005) 11(2):183-90. PubMed PMID: 15685173.
43. Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes (2002) 51(7):2005-11. PubMed PMID: 12086926.
44. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation (2005) 111(11):1448-54. PubMed PMID: 15781756.
45. Yang WH, Park SY, Nam HW, Kim do H, Kang JG, Kang ES, et al. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc Natl Acad Sci U S A (2008) 105(45):17345-50. PubMed PMID: 18988733.
46. Allison DF, Wamsley JJ, Kumar M, Li D, Gray LG, Hart GW, et al. Modification of RelA by O-linked N-acetylglucosamine links glucose metabolism to NF-kappaB acetylation and transcription. Proc Natl Acad Sci U S A (2012) 109(42):16888-93. PubMed PMID: 23027940.
47. Golks A, Tran TT, Goetschy JF, Guerini D. Requirement for O-linked Nacetylglucosaminyltransferase in lymphocytes activation. Embo J (2007) 26(20):4368-79. PubMed PMID: 17882263.
48. Ramakrishnan P, Clark PM, Mason DE, Peters EC, Hsieh-Wilson LC, Baltimore D. Activation of the transcriptional function of the NF-kappaB protein c-Rel by O-GlcNAc glycosylation. Sci Signal (2013) 6(290):ra75. PubMed PMID: 23982206.
49. Hart GW. Nutrient regulation of immunity: O-GlcNAcylation regulates stimulus-specific NFkappaB- dependent transcription. Sci Signal (2013) 6(290):pe26. PubMed PMID: 23982203.
50. Kawauchi K, Araki K, Tobiume K, Tanaka N. Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc Natl Acad Sci U S A (2009) 106(9):3431-6. PubMed PMID: 19202066.
51. Zou L, Yang S, Hu S, Chaudry IH, Marchase RB, Chatham JC. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels. Shock (2007) 27(4):402-8. PubMed PMID: 17414423.
52. Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, Marchase RB, et al. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. Am J Physiol Heart Circ Physiol (2009) 296(2):H515-23. PubMed PMID: 19098112.
53. Xing D, Gong K, Feng W, Nozell SE, Chen YF, Chatham JC, et al. O-GlcNAc modification of NFkappaB p65 inhibits TNF-alpha-induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One (2011) 6(8):e24021. PubMed PMID: 21904602.
54. Xing D, Feng W, Not LG, Miller AP, Zhang Y, Chen YF, et al. Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury. Am J Physiol Heart Circ Physiol (2008) 295(1):H335-42. PubMed PMID: 18469144.
55. Hilgers RH, Xing D, Gong K, Chen YF, Chatham JC, Oparil S. Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction. Am J Physiol Heart Circ Physiol (2012) 303(5):H513-22. PubMed PMID: 22777418.
56. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation (2003) 112(12):1821-30. PubMed PMID: 14679177.
57. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW, Jr. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation (2003) 112(12):1796-808. PubMed PMID: 14679176.
58. Obstfeld AE, Sugaru E, Thearle M, Francisco AM, Gayet C, Ginsberg HN, et al. C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesityinduced hepatic steatosis. Diabetes (2010) 59(4):916-25. PubMed PMID: 20103702.
59. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes (2007) 56(9):2356-70. PubMed PMID: 17579207.
60. Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Importance of primary capture and Lselectin- dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo. The Journal of experimental medicine (2001) 194(2):205-18. PubMed PMID: 11457895.
61. Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nature medicine (2012) 18(3):363-74. PubMed PMID: 22395709.
62. Stohr R, Federici M. Insulin resistance and atherosclerosis: convergence between metabolic pathways and inflammatory nodes. Biochem J (2013) 454(1):1-11. PubMed PMID: 23889252.
63. Shanmugam N, Reddy MA, Guha M, Natarajan R. High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes (2003) 52(5):1256-64. PubMed PMID: 12716761.
64. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes (2008) 57(11):3090-8. PubMed PMID: 18650365.
65. Hua KF, Wang SH, Dong WC, Lin CY, Ho CL, Wu TH. High glucose increases nitric oxide generation in lipopolysaccharide-activated macrophages by enhancing activity of protein kinase Calpha/delta and NF-kappaB. Inflamm Res (2012) 61(10):1107-16. PubMed PMID: 22706318.
66. Donath MY. Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov (2014) 13(6):465-76. PubMed PMID: 24854413.
67. Ptak W, Klimek M, Bryniarski K, Ptak M, Majcher P. Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals. Clin Exp Immunol (1998) 114(1):13-8. PubMed PMID: 9764597.
68. Wen Y, Gu J, Li SL, Reddy MA, Natarajan R, Nadler JL. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages. Endocrinology (2006) 147(5):2518-25. PubMed PMID: 16455783.
69. Sun C, Sun L, Ma H, Peng J, Zhen Y, Duan K, et al. The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J Cell Physiol (2012) 227(4):1670-9. PubMed PMID: 21678423.
70. Yamasawa H, Nakayama M, Bando M, Sugiyama Y. Impaired inflammatory responses to multiple toll-like receptor ligands in alveolar macrophages of streptozotocin-induced diabetic mice. Inflamm Res 61(5):417-26. PubMed PMID: 22228041.
71. Chikanishi T, Fujiki R, Hashiba W, Sekine H, Yokoyama A, Kato S. Glucose-induced expression of MIP-1 genes requires O-GlcNAc transferase in monocytes. Biochem Biophys Res Commun (2010) 394(4):865-70. PubMed PMID: 20206135.
72. Hwang SY, Shin JH, Hwang JS, Kim SY, Shin JA, Oh ES, et al. Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury. Glia (2010) 58(15):1881-92. PubMed PMID: 20737476.
73. Hwang SY, Hwang JS, Kim SY, Han IO. O-GlcNAcylation and p50/p105 binding of c-Rel are dynamically regulated by LPS and glucosamine in BV2 microglia cells. Br J Pharmacol (2013) 169(7):1551-60. PubMed PMID: 23646894.
74. Anagnostou SH, Shepherd PR. Glucose induces an autocrine activation of the Wnt/betacatenin pathway in macrophage cell lines. Biochem J (2008) 416(2):211-8. PubMed PMID: 18823284.
75. Hresko RC, Heimberg H, Chi MM, Mueckler M. Glucosamine-induced insulin resistance in 3T3-L1 adipocytes is caused by depletion of intracellular ATP. The Journal of biological chemistry (1998) 273(32):20658-68. PubMed PMID: 9685425.
76. Kaneto H, Xu G, Song KH, Suzuma K, Bonner-Weir S, Sharma A, et al. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. The Journal of biological chemistry (2001) 276(33):31099-104. PubMed PMID: 11390407.
77. Hwang SY, Hwang JS, Kim SY, Han IO. O-GlcNAc transferase inhibits LPS-mediated expression of inducible nitric oxide synthase through an increased interaction with mSin3A in RAW264.7 cells. Am J Physiol Cell Physiol (2013) 305(6):C601-8. PubMed PMID: 23824843.
78. Ryu IH, Do SI. Denitrosylation of S-nitrosylated OGT is triggered in LPS-stimulated innate immune response. Biochem Biophys Res Commun (2011) 408(1):52-7. PubMed PMID: 21453677.
79. Zheng GM, Yu C, Yang Z. Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-kappaB translocation. Int J Oncol (2012) 40(5):1610-8. PubMed PMID: 22246431.
80. Lima VV, Spitler K, Choi H, Webb RC, Tostes RC. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? Clin Sci (Lond) (2012) 123(8):473-86. PubMed PMID: 22757958.
81. Ma Z, Vocadlo DJ, Vosseller K. Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-kappaB Activity in Pancreatic Cancer Cells. The Journal of biological chemistry (2013) 288(21):15121-30. PubMed PMID: 23592772.
82. Torres CR, Hart GW. Topography and polypeptide distribution of terminal Nacetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. The Journal of biological chemistry (1984) 259(5):3308-17. PubMed PMID: 6421821.
83. Kearse KP, Hart GW. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc Natl Acad Sci U S A (1991) 88(5):1701-5. PubMed PMID: 2000378.